In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 763114-26-7, name is 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid, introducing its new discovery. Computed Properties of C16H11FN2O3
Containing the phthalazine -1 (2 H) – one structure of PARP – 1 and PI3K double-target inhibitors (by machine translation)
The invention relates to the field of pharmaceutical chemistry, in particular relates to a containing phthalazine – 1 (2 H) – one and triazine or pyrimidine structure of PARP – 1 and PI3K double-target inhibitor (I), processes for their preparation, and pharmaceutical compositions containing these compounds. The pharmacodynamics experiment proves that the compounds of this invention have anti-tumor efficacy. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 763114-26-7, and how the biochemistry of the body works.Computed Properties of C16H11FN2O3
Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N775 – PubChem